// App-Quantinova.ai

17857 : Calpain-2 Protects Against Doxorubicin-Induced Cardiac Toxicity

Researchers

Presenter

  • Rui Ni

Principal Investigators

  • Yanpeng Wang

  • Tianqing Peng

Medical Centers

  • LAWSON HEALTH RESEARCH INST, London, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial Dysfunction

  • Cardiotoxicity

  • Heart muscle disease

Biomarkers

  • Histone H2AX

Drug/Treatment

  • Doxorubicin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved